Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Rheumatology|November 17, 2010
ERAP1 is associated with ankylosing spondylitis in Han ChineseChao Li, Zhiming Lin, Yingying Xie, et al.
JMIR Mhealth and Uhealth|June 5, 2019
Using Mobile Apps for Health Management: A New Health Care Mode in ChinaQing Lv, Yutong Jiang, Jun Qi, et al.
Polymers|December 11, 2025
Dual-Triggered Release Mechanisms in Calcium Alginate/Fe3O4 Capsules for Asphalt Self-Healing: Cyclic Load-Induced Sustained Release and Microwave-Activated On-Demand DeliveryPei Wan, Jiazhu Wang, Zirong Ma, et al.
Rheumatology International|December 17, 2009
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patientsZhiming Lin, Jieruo Gu, Peigen He, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Effects and safety of 99Tc-MDP in patients with refractory ankylosing spondylitis: a 2-stage (30-week follow-up) clinical trialYunyun Xu, Yi Zhong, Minjing Zhao, et al.
Frontiers in Molecular Neuroscience|July 28, 2026
Altered cortical neuronal activity in functional esophageal disorders and its associations with chronic insomnia and peripheral inflammation: a resting-state fMRI studyBei Peng, Likun Zhong, Jinfu Huang, et al.
Biomed Research International|August 15, 2015
Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic TargetsQing Lv, Qiuxia Li, Peizhuo Zhang, et al.
International Journal of Rheumatic Diseases|August 18, 2012
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitisZaiying Hu, Manlong Xu, Qiuxia Li, et al.
Frontiers in Pharmacology|March 27, 2020
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative StudyJialing Wu, Xinyu Wu, Zena Chen, et al.
Arthritis Research & Therapy|June 21, 2020
TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitisMingcan Yang, Qing Lv, Qiujing Wei, et al.
Pageof 10